Won Jun Kim
Overview
Explore the profile of Won Jun Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hong S, Kim W, Kang E, Jeong I, Kim C, Lee K, et al.
Diabetes Obes Metab
. 2024 Dec;
27(3):1242-1250.
PMID: 39703109
Aims: This study evaluated the efficacy and safety of a combination of phentermine and delayed-release topiramate (PHEN/TPM CR) versus placebo as an adjunct to standard lifestyle recommendations in Korean adults....
2.
Kim N, Lee J, Chon S, Yu J, Jeong I, Lim S, et al.
Endocrinol Metab (Seoul)
. 2024 Aug;
39(5):722-731.
PMID: 39174014
Backgruound: Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of vascular complications. Statin therapy is the primary approach to dyslipidemia...
3.
Yoon K, Lee J, Song Y, Kim W, Shim M, Kim H, et al.
Head Neck
. 2024 Aug;
47(1):215-224.
PMID: 39092655
Background: Accurate intraoperative identification of normal parathyroid glands (PTGs) is vital to avoid hypocalcemia post total thyroidectomy. Although ultrasonography (US) has been shown to identify normal PTGs, the significance of...
4.
Mittal K, Cooper G, Lee B, Su Y, Skinner K, Shim J, et al.
Commun Biol
. 2024 Apr;
7(1):426.
PMID: 38589567
Wilms tumor (WT) is the most common renal malignancy of childhood. Despite improvements in the overall survival, relapse occurs in ~15% of patients with favorable histology WT (FHWT). Half of...
5.
Kim W
Korean J Gastroenterol
. 2024 Mar;
83(3):94-101.
PMID: 38522852
The prevalence of obesity with various complications is increasing rapidly in Korea. Although lifestyle modification is fundamental in obesity treatment, more effective treatment tools are required. Many advances in obesity...
6.
Kim W, Kil B, Lee C, Kim T, Han G, Choi Y, et al.
Gut Microbes
. 2024 Feb;
16(1):2319889.
PMID: 38391178
The gut microbiota plays a pivotal role in metabolic disorders, notably type 2 diabetes mellitus (T2DM). In this study, we investigated the synergistic potential of combining the effects of NBM7-1...
7.
Montoya S, Bourcier J, Noviski M, Lu H, Thompson M, Chirino A, et al.
Science
. 2024 Feb;
383(6682):eadi5798.
PMID: 38301010
Increasing use of covalent and noncovalent inhibitors of Bruton's tyrosine kinase (BTK) has elucidated a series of acquired drug-resistant BTK mutations in patients with B cell malignancies. Here we identify...
8.
Dunbar A, Bowman R, Park Y, OConnor K, Izzo F, Myers R, et al.
Cancer Discov
. 2024 Jan;
14(5):737-751.
PMID: 38230747
Significance: Current JAK inhibitors to treat myeloproliferative neoplasms are ineffective at eradicating mutant cells. We developed an endogenously expressed Jak2V617F dual-recombinase knock-in/knock-out model to investigate Jak2V617F oncogenic reversion in vivo....
9.
Kim M, Kim J, Song Y, Hong S, Won H, Kim W, et al.
Obes Rev
. 2023 Dec;
25(3):e13670.
PMID: 38049310
Bariatric surgery can cause numerous functional changes to recipients, some of which are unintended. However, a systematic evaluation of wide-angled health benefits and risks following bariatric surgery has not been...
10.
Kim W, Lee Y, Kim H, Ryu J, Yang J, Lee S
Cell Syst
. 2023 Nov;
14(11):990-1001.e5.
PMID: 37935194
In metabolic engineering, predicting gene overexpression targets remains challenging because both endogenous and heterologous genes in a large metabolic space can be candidates, in contrast to gene knockout targets that...